Social Media

Many thanks to British Journal of Cardiology for giving me this platform to discuss a topic that is hugely important yet underreported 🙏🏾 Cardiac ATTR amyloidosis…

Happening today! 🚨 Join HFSA's Cardio Town Hall: Expert Perspectives on Contemporary ATTR-CM Clinical Research for a live discussion on the latest clinical…

What happens when your body starts telling you something is seriously wrong?While working overseas, Al Boykin began experiencing symptoms he couldn’t ignore. After…

It's PersonalPeople often ask why I'm so passionate about hereditary ATTR amyloidosis.The answer is simple.This isn't just something I advocate for.It's something…

Transform the way you recognize and manage ATTR-CM.Join renowned experts for an in-depth scientific webinar exploring the latest advances in diagnosis, clinical…

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient…

ATTR-CM: Let's Separate Fact from FictionWhen it comes to transthyretin amyloid cardiomyopathy (ATTR-CM), misinformation can delay diagnosis and treatment.Swipe…

Amyloidosis is a great masquerader, presenting with a wide array of seemingly unconnected symptoms. This reality is likely one of the biggest reasons for…

Early-career clinicians need stronger training on inherited disease patterns in the Black diaspora to close critical awareness gaps.Most hereditary conditions like…

New drug therapies have greatly improved outcomes for this common cause of heart failure. Cardiologist Dr. Thomas O’Neill explains more.